Skip to content

Benzodiazepines Deprescribing in Nursing Homes: Intervention Feasibility

Feasibility of a Theory-based Benzodiazepines Deprescribing Intervention in Belgian Nursing Homes: the END-IT Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05929443
Acronym
END-IT NH
Enrollment
80
Registered
2023-07-03
Start date
2023-06-22
Completion date
2024-06-30
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benzodiazepines Deprescribing

Keywords

Benzodiazepines, Deprescribing, Long-term care, Older adults

Brief summary

The goal of this feasibility study is to evaluate the feasibility of a complex intervention towards benzodiazepines and Z-drugs deprescribing in older adults living in the Belgian nursing home setting. The main questions it aims to answer are: * Is the intervention we developped feasible * To what extent will the intervention be implemented in nursing homes * To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants Participants will benefit from a complex intervention implemented at the level of the nursing home, encompassing process and goals setting, healthcare providers education, environmental adaptations, audit and feedback on benzodiazepines use, use of educational leaflet with residents and relatives, and multidisciplinary work. Researchers will compare this intervention to usual care, to see if the intervention is feasible, and to gather first data on intervention effectiveness in benzodiazepines deprescriping.

Interventions

OTHEREND-IT intervention for nursing homes

Complex intervention, as described in the arm/group descriptions

Sponsors

EBPracticenet
CollaboratorUNKNOWN
Fonds National de la Recherche scientifique (FNRS)
CollaboratorUNKNOWN
Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 65 years old and older * Taking at least one benzodiazepine or Z-drug for 4 weeks or more

Exclusion criteria

* Unability to communicate in French * Palliative care * Ongoing benzodiazepine withdrawal * Ongoing alcohol withdrawal * Severe anxiety * Severe depression

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the data collection processAt 6 monthsData collection process will be assessed through the quality of collected data (rate of missing data)
Nursing homes' adherence to the interventionAssessed at 6 monthshas the intervention been implemented as intended, e.g. global number of implemented intervention components
Healthcare providers responsiveness to the interventionAssessed at 6 monthshas far did they respond to the intervention, and how far have them been engaged by the intervention, e.g level of attendance to education session for healthcare providers
nursing home residents' responsiveness to the interventionAssessed at 6 monthshas far did they respond to the intervention, and how far have them been engaged by the intervention
Feasibility of the recruitment processAt 6 monthsThe feasibility of the recruitment will be assessed through the ratio between included residents and residents contacted for participation.

Secondary

MeasureTime frameDescription
Contextual factors at the level of the nursing home residentBaselineUse of a questionnaire to assess factors that could explain potential differences in intervention implementation between nursing home residents
Intervention mechanisms of impactAt baselineUse of a questionnaire to assess intervention mechanisms of impact, in relation with how the intervention is supposed to have its impact
Exploratory benzodiazepine deprescribing rate analysisAt 3 monthsDefined as either a complete benzodiazepine/Z-drug cessation, or a dose reduction
Contextual factors at the level of of the nursing homeBaselineUse of a questionnaire to assess factors that could explain potential differences in intervention implementation between nursing homes

Countries

Belgium

Contacts

Primary ContactPerrine Evrard, MPharm
perrine.evrard@uclouvain.be+3227647236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026